Yuko Goto-Koshino Selected Research

Yuko Goto-Koshino Research Topics

Disease

26	Lymphoma (Lymphomas) 12/2023 - 12/2008
25	Neoplasms (Cancer) 11/2023 - 12/2008
9	B-Cell Lymphoma (Lymphoma, B Cell) 11/2023 - 04/2011
6	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 08/2014 - 12/2011
4	T-Cell Lymphoma (Lymphoma, T Cell) 12/2023 - 07/2017
4	Infections 01/2023 - 01/2009
4	Non-Hodgkin Lymphoma (Lymphosarcoma) 09/2014 - 09/2010
3	Inflammation (Inflammations) 08/2014 - 10/2012
2	Plasmacytoma 02/2024 - 07/2020
2	Carcinoma (Carcinomatosis) 01/2021 - 08/2014
2	Polyps 04/2020 - 04/2015
2	Histiocytic Sarcoma 07/2019 - 10/2017
1	Thrombocytopenia (Thrombopenia) 02/2024
1	Neutropenia 02/2024
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2023
1	Mucocele 12/2023
1	Liver Cell Adenoma (Hepatocellular Adenoma) 06/2023
1	Enteritis 01/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2022
1	Enteropathy-Associated T-Cell Lymphoma 01/2022
1	Lymphocytosis 01/2022
1	Thrombophilia 08/2021
1	Protein-Losing Enteropathies (Protein-Losing Enteropathy) 08/2021
1	Amyloidosis 07/2020
1	Lymphadenopathy 01/2020
1	Hepatolenticular Degeneration (Wilson's Disease) 01/2020
1	Cystitis 01/2020
1	Jaundice (Icterus) 03/2019
1	Anorexia 03/2019
1	Lethargy 03/2019
1	Inborn Genetic Diseases (Disease, Hereditary) 03/2019
1	Hyperammonemia 03/2019
1	Gallbladder Diseases (Gall Bladder Disease) 10/2018
1	Hodgkin Disease (Hodgkin's Disease) 09/2017
1	Hypoxia (Hypoxemia) 01/2017
1	Pancreatitis 01/2017
1	Circulating Neoplastic Cells 06/2016

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 12/2023 - 09/2010
8	Messenger RNA (mRNA)IBA 12/2023 - 09/2010
4	Indicators and Reagents (Reagents)IBA 09/2016 - 01/2012
4	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 05/2015 - 12/2008
3	Granzymes (Granzyme)IBA 12/2023 - 01/2022
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 12/2023 - 01/2012
3	EnzymesIBA 06/2023 - 03/2019
3	Serum Amyloid A Protein (Serum Amyloid A)IBA 05/2017 - 09/2013
3	Biomarkers (Surrogate Marker)IBA 01/2017 - 09/2013
3	Antigen Receptors (Antigen Receptor)IBA 09/2016 - 06/2015
3	ChemokinesIBA 01/2012 - 12/2011
2	MucinsIBA 12/2023 - 10/2018
2	Melphalan (Alkeran)FDA LinkGeneric 01/2023 - 06/2015
2	CytokinesIBA 05/2022 - 08/2014
2	Prednisolone (Predate)FDA LinkGeneric 04/2020 - 10/2018
2	ParaffinIBA 01/2020 - 01/2012
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 09/2010
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 05/2017 - 08/2014
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017 - 06/2015
2	C-Reactive ProteinIBA 01/2017 - 09/2011
2	NimustineIBA 06/2015 - 06/2014
2	Chemokine CX3CL1IBA 08/2012 - 01/2012
2	Chemokine ReceptorsIBA 01/2012 - 12/2011
2	Complementarity Determining Regions (Complementarity Determining Region)IBA 01/2012 - 09/2011
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2024
1	Blood Proteins (Serum Proteins)IBA 02/2024
1	Alkylating AgentsIBA 01/2023
1	Chlorambucil (Leukeran)FDA Link 01/2023
1	Asparaginase (Elspar)FDA Link 03/2022
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2022
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	mogamulizumabIBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	5- (benzoylamino)- N- (4- chlorophenyl)- 3- methyl- 4- isothiazolecarboxamide (ITCL)IBA 01/2022
1	CCR4 ReceptorsIBA 01/2021
1	Chemokine CCL17IBA 01/2021
1	Amyloid (Amyloid Fibrils)IBA 07/2020
1	Interleukin-2 Receptor alpha SubunitIBA 07/2020
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 07/2020
1	Leflunomide (Arava)FDA LinkGeneric 04/2020
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 04/2020
1	Formaldehyde (Formol)FDA Link 01/2020
1	NucleotidesIBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 07/2019
1	CopperIBA 03/2019
1	GlucocorticoidsIBA 10/2018
1	Protein Isoforms (Isoforms)IBA 09/2018
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 07/2017
1	toceranib phosphateIBA 07/2017
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 07/2017
1	matrigelIBA 05/2017
1	TH 302IBA 01/2017
1	ProdrugsIBA 01/2017
1	MicroRNAs (MicroRNA)IBA 08/2015

Therapy/Procedure

11	Drug Therapy (Chemotherapy) 11/2023 - 12/2008
6	Therapeutics 02/2024 - 04/2011
3	Immunotherapy 01/2022 - 07/2009
1	Remission Induction 11/2023
1	Aftercare (After-Treatment) 08/2021
1	Radiotherapy 04/2021
1	Molecular Targeted Therapy 05/2016